First Trust Advisors
KNSA icon

First Trust Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

First Trust Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$658K Buy
10,291
+415
+4% +$21.5K ﹤0.01% 2344
2026
Q1 		$476K Buy
9,876
+293
+3% +$13K ﹤0.01% 2365
2025
Q4 		$395K Buy
9,583
+1,518
+19% +$60.9K ﹤0.01% 2386
2025
Q3 		$313K Sell
8,065
-20,373
-72% -$662K ﹤0.01% 2404
2025
Q2 		$787K Buy
+28,438
New +$724K ﹤0.01% 2143

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

First Trust Advisors's KNSA Position: Q2 2026 in Review

First Trust Advisors increased its Kiniksa Pharmaceuticals (KNSA) stake by 4.2% in Q2 2026, buying an estimated $21.5K and bringing the position to 10,291 shares worth $658K. The position accounts for ﹤0.01% of the portfolio, ranked #2344.

First Trust Advisors first reported a position in KNSA in Q2 2025 and has held it in 5 quarters since. The position peaked at $787K in Q2 2025. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • First Trust Advisors held 10,291 shares of Kiniksa Pharmaceuticals worth $658K as of Q2 2026.
  • First Trust Advisors bought 415 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $21.5K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #2344 holding.
  • First Trust Advisors first reported a position in Kiniksa Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • First Trust Advisors's Kiniksa Pharmaceuticals position peaked at $787K in Q2 2025.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.